59 related articles for article (PubMed ID: 38742843)
21. Osteosarcoma: Current Concepts and Evolutions in Management Principles.
Pilavaki P; Gahanbani Ardakani A; Gikas P; Constantinidou A
J Clin Med; 2023 Apr; 12(8):. PubMed ID: 37109122
[TBL] [Abstract][Full Text] [Related]
22. Tumor-associated macrophages induce inflammation and drug resistance in a mechanically tunable engineered model of osteosarcoma.
Chim LK; Williams IL; Bashor CJ; Mikos AG
Biomaterials; 2023 May; 296():122076. PubMed ID: 36931102
[TBL] [Abstract][Full Text] [Related]
23. Managing the immune microenvironment of osteosarcoma: the outlook for osteosarcoma treatment.
Tian H; Cao J; Li B; Nice EC; Mao H; Zhang Y; Huang C
Bone Res; 2023 Feb; 11(1):11. PubMed ID: 36849442
[TBL] [Abstract][Full Text] [Related]
24. Abnormal signal pathways and tumor heterogeneity in osteosarcoma.
Sun Y; Zhang C; Fang Q; Zhang W; Liu W
J Transl Med; 2023 Feb; 21(1):99. PubMed ID: 36759884
[TBL] [Abstract][Full Text] [Related]
25. Osteosarcoma.
Beird HC; Bielack SS; Flanagan AM; Gill J; Heymann D; Janeway KA; Livingston JA; Roberts RD; Strauss SJ; Gorlick R
Nat Rev Dis Primers; 2022 Dec; 8(1):77. PubMed ID: 36481668
[TBL] [Abstract][Full Text] [Related]
26. CD36 and Its Role in Regulating the Tumor Microenvironment.
Liao X; Yan S; Li J; Jiang C; Huang S; Liu S; Zou X; Zhang G; Zou J; Liu Q
Curr Oncol; 2022 Oct; 29(11):8133-8145. PubMed ID: 36354702
[TBL] [Abstract][Full Text] [Related]
27. A novel immune cell signature for predicting osteosarcoma prognosis and guiding therapy.
Pan R; Pan F; Zeng Z; Lei S; Yang Y; Yang Y; Hu C; Chen H; Tian X
Front Immunol; 2022; 13():1017120. PubMed ID: 36189307
[TBL] [Abstract][Full Text] [Related]
28. Immune checkpoints in osteosarcoma: Recent advances and therapeutic potential.
Wen Y; Tang F; Tu C; Hornicek F; Duan Z; Min L
Cancer Lett; 2022 Oct; 547():215887. PubMed ID: 35995141
[TBL] [Abstract][Full Text] [Related]
29. High-throughput methods for genome editing: the more the better.
Huang Y; Shang M; Liu T; Wang K
Plant Physiol; 2022 Mar; 188(4):1731-1745. PubMed ID: 35134245
[TBL] [Abstract][Full Text] [Related]
30. Osteosarcoma from the unknown to the use of exosomes as a versatile and dynamic therapeutic approach.
Santos A; Domingues C; Jarak I; Veiga F; Figueiras A
Eur J Pharm Biopharm; 2022 Jan; 170():91-111. PubMed ID: 34896571
[TBL] [Abstract][Full Text] [Related]
31. New Horizons in the Treatment of Osteosarcoma.
Meltzer PS; Helman LJ
N Engl J Med; 2021 Nov; 385(22):2066-2076. PubMed ID: 34818481
[No Abstract] [Full Text] [Related]
32. Preoperative prognostic nutritional index and systemic immune-inflammation index predict survival outcomes in osteosarcoma: A comparison between young and elderly patients.
Ma C; Yu R; Li J; Guo J; Xu J; Wang X; Liu P
J Surg Oncol; 2022 Mar; 125(4):754-765. PubMed ID: 34811745
[TBL] [Abstract][Full Text] [Related]
33. Osteosarcoma: Old and New Challenges.
Yoshida A
Surg Pathol Clin; 2021 Dec; 14(4):567-583. PubMed ID: 34742481
[TBL] [Abstract][Full Text] [Related]
34. Osteosarcoma mechanobiology and therapeutic targets.
Shoaib Z; Fan TM; Irudayaraj JMK
Br J Pharmacol; 2022 Jan; 179(2):201-217. PubMed ID: 34679192
[TBL] [Abstract][Full Text] [Related]
35. Three Differential Expression Analysis Methods for RNA Sequencing: limma, EdgeR, DESeq2.
Liu S; Wang Z; Zhu R; Wang F; Cheng Y; Liu Y
J Vis Exp; 2021 Sep; (175):. PubMed ID: 34605806
[TBL] [Abstract][Full Text] [Related]
36. NLRP3 Overexpression Associated With Poor Prognosis and Presented as an Effective Therapeutic Target in Osteosarcoma.
Huang Z; Chen H; Wang S; Wei H; Wang X; Shen R; Wang Y; Lin R; Lin J
Front Pharmacol; 2021; 12():724923. PubMed ID: 34393801
[TBL] [Abstract][Full Text] [Related]
37. A method of sample-wise region-set enrichment analysis for DNA methylomics.
Minegishi R; Gotoh O; Tanaka N; Maruyama R; Chang JT; Mori S
Epigenomics; 2021 Jul; 13(14):1081-1093. PubMed ID: 34241544
[TBL] [Abstract][Full Text] [Related]
38. Advancing therapy for osteosarcoma.
Gill J; Gorlick R
Nat Rev Clin Oncol; 2021 Oct; 18(10):609-624. PubMed ID: 34131316
[TBL] [Abstract][Full Text] [Related]
39. Bulk and single-cell transcriptome profiling reveal the metabolic heterogeneity in human breast cancers.
Yu TJ; Ma D; Liu YY; Xiao Y; Gong Y; Jiang YZ; Shao ZM; Hu X; Di GH
Mol Ther; 2021 Jul; 29(7):2350-2365. PubMed ID: 33677091
[TBL] [Abstract][Full Text] [Related]
40. Future Directions in the Treatment of Osteosarcoma.
Smrke A; Anderson PM; Gulia A; Gennatas S; Huang PH; Jones RL
Cells; 2021 Jan; 10(1):. PubMed ID: 33467756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
